DWF Guides Cancer Biotech Biz BiVictriX On Quitting AIM
BiVictriX Therapeutics PLC proposed on Monday to cancel its listing on the junior Alternative Investment Market in London and go private, citing poor fundraising prospects and the cost of being on...To view the full article, register now.
Already a subscriber? Click here to view full article